After a promising feasibility study showing the potential of its natural language processing models, MSK has ambitions to use them in patient care.
Researchers will use the funds to identify molecular signatures linked to different disease subtypes and test drugs on brain organoids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback